首页> 外国专利> Isolated in vitro cell population comprising primate pluripotent stem cells containing a nucleic acid construct and differentiated progeny of the pluripotent stem cells

Isolated in vitro cell population comprising primate pluripotent stem cells containing a nucleic acid construct and differentiated progeny of the pluripotent stem cells

机译:分离的体外细胞群,包含灵长类多能干细胞,该干细胞含有核酸构建体和多能干细胞的分化后代

摘要

This invention provides a system for producing differentiated cells from a stem cell population for use wherever a relatively homogenous cell population is desirable. The cells contain an effector gene under control of a transcriptional control element (such as the TERT promoter) that causes the gene to be expressed in relatively undifferentiated cells in the population. Expression of the effector gene results in depletion of undifferentiated cells, or expression of a marker that can be used to remove them later. Suitable effector sequences encode a toxin, a protein that induces apoptosis; a cell-surface antigen, or an enzyme (such as thymidine kinase) that converts a prodrug into a substance that is lethal to the cell. The differentiated cell populations produced according to this disclosure are suitable for use in tissue regeneration, and non-therapeutic applications such as drug screening.
机译:本发明提供了一种用于从干细胞群体生产分化细胞的系统,该系统可用于需要相对同质的细胞群体的任何地方。所述细胞包含在转录控制元件(例如TERT启动子)的控制下的效应基因,所述效应导致所述基因在群体中相对未分化的细胞中表达。效应子基因的表达导致未分化细胞的耗竭,或可用于以后去除它们的标记物的表达。合适的效应子序列编码一种毒素,一种诱导细胞凋亡的蛋白质。细胞表面抗原或将前药转化为对细胞具有致命性的物质的酶(例如胸苷激酶)。根据本公开内容产生的分化的细胞群适合用于组织再生和非治疗性应用,例如药物筛选。

著录项

  • 公开/公告号US9023645B2

    专利类型

  • 公开/公告日2015-05-05

    原文格式PDF

  • 申请/专利权人 ASTERIAS BIOTHERAPEUTICS INC.;

    申请/专利号US201313837522

  • 发明设计人 JOSEPH D GOLD;JANE S LEBKOWSKI;

    申请日2013-03-15

  • 分类号C12N5/02;C12N15;C12N15/85;C12N5/0735;A61K35/12;

  • 国家 US

  • 入库时间 2022-08-21 15:17:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号